secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2022-06-14T23:59:59+00:00
Accession:  0001213900-22-032619
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma shareholders elect six directors and ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- All six director nominees elected: Keyser, Sharma, Chandru, Maccecchini, Prendergast, Silberstein.
- EisnerAmper LLP ratified as independent auditor for FY 2022 with 7.48M shares for, 18,585 against.
- Director votes ranged from 3.85M to 3.85M for; broker non-votes of 3.67M on each director election.
- No broker non-votes on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000121390022032619/0001213900-22-032619-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000121390022032619/ea161518-8k_lantern.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-032619

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer